{"id":"https://openalex.org/W2405075005","doi":null,"title":"DNA binding compounds targeting fungal pathogens: an emerging concept in the discovery of novel antifungal agents.","display_name":"DNA binding compounds targeting fungal pathogens: an emerging concept in the discovery of novel antifungal agents.","publication_year":2002,"publication_date":"2002-10-01","ids":{"openalex":"https://openalex.org/W2405075005","mag":"2405075005","pmid":"https://pubmed.ncbi.nlm.nih.gov/12431015"},"language":"en","primary_location":{"id":"pmid:12431015","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12431015","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108353169","display_name":"Lillian L. Lou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lillian Lou","raw_affiliation_strings":["Genelabs Technologies Inc., Redwood City, CA 94063, USA. LillianL@genelabs.com","Genelabs Technologies Inc., Redwood City, CA 94063, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genelabs Technologies Inc., Redwood City, CA 94063, USA. LillianL@genelabs.com","institution_ids":[]},{"raw_affiliation_string":"Genelabs Technologies Inc., Redwood City, CA 94063, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071347002","display_name":"Mark Velligan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Velligan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108350566","display_name":"Christopher C. Roberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Roberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021143803","display_name":"David A. Stevens","orcid":"https://orcid.org/0000-0002-5861-5716","observed_orcids":["https://orcid.org/0000-0002-5861-5716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A Stevens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014273536","display_name":"Karl V. Clemons","orcid":"https://orcid.org/0000-0001-5138-6896","observed_orcids":["https://orcid.org/0000-0001-5138-6896"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl V Clemons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.221,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.63773929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"3","issue":"10","first_page":"1437","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11900","display_name":"Fungal Plant Pathogen Control","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/1105","display_name":"Ecology, Evolution, Behavior and Systematics"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-binding-compounds","display_name":"DNA-binding compounds","score":0.7409999966621399},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.9679999947547913},{"id":"https://openalex.org/keywords/minor-groove-binders","display_name":"minor groove binders","score":0.7929999828338623},{"id":"https://openalex.org/keywords/fungal-drug-resistance","display_name":"fungal drug resistance","score":0.8059999942779541},{"id":"https://openalex.org/keywords/pathogenic-yeasts","display_name":"pathogenic yeasts","score":0.8790000081062317},{"id":"https://openalex.org/keywords/molds","display_name":"molds","score":0.9369999766349792},{"id":"https://openalex.org/keywords/candidiasis","display_name":"candidiasis","score":0.7960000038146973},{"id":"https://openalex.org/keywords/fungicidal-activity","display_name":"fungicidal activity","score":0.828000009059906},{"id":"https://openalex.org/keywords/small-molecule-drug-discovery","display_name":"small molecule drug discovery","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.6547912359237671},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.5791419744491577},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.574742317199707},{"id":"https://openalex.org/C74600772","wikidata":"https://www.wikidata.org/wiki/Q193237","display_name":"Fungicide","level":2,"score":0.4996476173400879},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.48314163088798523},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4738752543926239},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4040288031101227},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.3668544292449951},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.322753369808197},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011020","descriptor_name":"Pneumonia, Pneumocystis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D025141","descriptor_name":"Drug Resistance, Fungal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12431015","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12431015","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:2405075005","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12431015","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392821510","https://openalex.org/W2063412100","https://openalex.org/W4232741190","https://openalex.org/W4283445801","https://openalex.org/W2062962104","https://openalex.org/W7096804979","https://openalex.org/W2981892507","https://openalex.org/W4301862796","https://openalex.org/W108820446","https://openalex.org/W4403781196"],"abstract_inverted_index":{"With":[0],"the":[1,17,42,59],"urgent":[2],"need":[3],"for":[4],"novel":[5],"agents":[6],"to":[7,12,32,39,41,49],"combat":[8],"emerging":[9],"fungal":[10],"resistance":[11],"existing":[13],"drugs,":[14],"activity":[15],"in":[16,90],"exploration":[18],"of":[19,36,45,78,94],"small":[20],"molecule":[21],"DNA":[22,46,67],"binders":[23],"has":[24],"increased.":[25],"Recently,":[26],"selected":[27,85],"cationic":[28],"heterocyclic":[29],"compounds":[30,72],"belonging":[31],"a":[33,76,84,91],"broad":[34],"class":[35],"molecules":[37,55],"known":[38],"bind":[40],"minor":[43],"groove":[44],"were":[47],"revealed":[48],"have":[50],"potent":[51],"antifungal":[52],"activity.":[53],"These":[54],"are":[56,73],"different":[57],"from":[58],"conventional":[60],"DNA-interacting":[61],"drugs":[62],"such":[63],"as":[64],"topoisomerase":[65],"inhibitors,":[66],"alkylators":[68],"or":[69],"intercalators.":[70],"Selected":[71],"fungicidal":[74],"towards":[75],"variety":[77],"pathogenic":[79],"yeasts":[80],"and":[81,83],"molds,":[82],"lead":[86],"compound":[87],"is":[88],"efficacious":[89],"mouse":[92],"model":[93],"systemic":[95],"candidosis.":[96]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}